OA12121A - Matrix tablet for prolonged release of trimetazidine after oral administration. - Google Patents

Matrix tablet for prolonged release of trimetazidine after oral administration. Download PDF

Info

Publication number
OA12121A
OA12121A OA1200200181A OA1200200181A OA12121A OA 12121 A OA12121 A OA 12121A OA 1200200181 A OA1200200181 A OA 1200200181A OA 1200200181 A OA1200200181 A OA 1200200181A OA 12121 A OA12121 A OA 12121A
Authority
OA
OAPI
Prior art keywords
matrix tablet
tablet according
trimetazidine
matrix
total mass
Prior art date
Application number
OA1200200181A
Other languages
English (en)
Inventor
Bruno Huet De Barochez
Patrick Wuthrich
Claude Dauphant
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9553398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA12121(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of OA12121A publication Critical patent/OA12121A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA1200200181A 1999-12-17 2000-12-15 Matrix tablet for prolonged release of trimetazidine after oral administration. OA12121A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9915960A FR2802424B1 (fr) 1999-12-17 1999-12-17 Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale

Publications (1)

Publication Number Publication Date
OA12121A true OA12121A (en) 2003-10-20

Family

ID=9553398

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200181A OA12121A (en) 1999-12-17 2000-12-15 Matrix tablet for prolonged release of trimetazidine after oral administration.

Country Status (33)

Country Link
EP (1) EP1108424B2 (de)
JP (2) JP2001172181A (de)
KR (1) KR100456933B1 (de)
CN (1) CN1166408C (de)
AR (1) AR026968A1 (de)
AT (1) ATE296622T1 (de)
AU (1) AU780011B2 (de)
BG (1) BG65773B1 (de)
BR (1) BR0005915A (de)
CY (1) CY2347B1 (de)
CZ (1) CZ299461B6 (de)
DE (1) DE60020501T3 (de)
DK (1) DK1108424T4 (de)
EA (2) EA008223B1 (de)
ES (2) ES2240033T5 (de)
FR (1) FR2802424B1 (de)
GE (1) GEP20053540B (de)
GR (1) GR1003658B (de)
HK (1) HK1036937A1 (de)
HU (1) HU226956B1 (de)
IE (1) IE20001017A1 (de)
IT (1) IT1317075B1 (de)
LU (1) LU90700B1 (de)
MX (1) MXPA00012462A (de)
NZ (1) NZ508912A (de)
OA (1) OA12121A (de)
PL (1) PL206994B1 (de)
PT (2) PT1108424E (de)
SI (1) SI1108424T2 (de)
SK (1) SK286752B6 (de)
UA (1) UA80087C2 (de)
WO (1) WO2001043747A1 (de)
ZA (1) ZA200007548B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1195160B1 (de) * 2000-10-05 2009-09-16 USV Ltd. Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
CN1842333A (zh) * 2003-08-04 2006-10-04 杏林制药株式会社 口服缓释片剂
SG126792A1 (en) * 2005-04-27 2006-11-29 Servier Lab Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
FR2885807B1 (fr) * 2005-05-18 2008-05-16 Mg Pharma Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation
CZ300307B6 (cs) * 2006-01-04 2009-04-15 Zentiva, A. S. Tableta s obsahem trimetazidinu nebo jeho farmakologicky akceptovatelné soli s modifikovaným uvolnováním
EA009776B1 (ru) * 2006-07-18 2008-04-28 Мераб Ревазович Кокеладзе Способ изготовления таблетированной лекарственной формы триметазидина дигидрохлорида и ее состав
EA009810B1 (ru) * 2006-12-26 2008-04-28 Закрытое Акционерное Общество "Канонфарма Продакшн" Матрица для изготовления таблетированной лекарственной формы и способ лечения
EP2200591A2 (de) * 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Pharmazeutische dosierungsformen von trimetazidin mit verzögerter freisetzung
EP2389167A2 (de) 2009-01-20 2011-11-30 Micro Labs Limited Feste pharmazeutische zusammensetzungen aus trimetazidin mit modifizierter freisetzung und verfahren dafür
EP2391353B1 (de) * 2009-01-30 2016-02-10 Lupin Limited Pharmazeutische zusammensetzungen von trimetazidin
TR201001902A2 (tr) 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Uzatılmış salınımlı trimetazidin tablet
RU2445958C2 (ru) * 2010-04-20 2012-03-27 Общество с ограниченной ответственностью "Озон" (ООО "Озон") Матричная таблетка с основой для пролонгированного высвобождения триметазидина и способ ее изготовления
US20110274751A1 (en) 2010-05-04 2011-11-10 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Trimetazidine formulation with different release profiles
EP2386302A1 (de) 2010-05-11 2011-11-16 Ranbaxy Laboratories Limited Pharmazeutische Dosierungsform von Trimetazidin mit verzögerter Freisetzung und Herstellungsverfahren dafür
EP2491930A1 (de) 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmazeutische Kombination von Betahistin mit Trimetazidin
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
FR2986431B1 (fr) 2012-02-03 2017-03-17 Servier Lab Composition pharmaceutique a liberation prolongee de trimetazidine, son procede de fabrication et son utilisation dans des traitements therapeutiques
CN102824644B (zh) * 2012-09-13 2013-12-25 浙江诚意药业有限公司 使用羟丙基纤维素制备的高稳定性的缓释片
KR20160118733A (ko) 2015-04-03 2016-10-12 이인현 호스 권취용 호스 안내장치 및 이를 구비한 호스 권취기
CN109316455B (zh) * 2017-07-31 2021-05-25 北京福元医药股份有限公司 一种盐酸曲美他嗪缓释片
CN109908096A (zh) * 2017-12-12 2019-06-21 武汉武药科技有限公司 一种盐酸曲美他嗪缓释片及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
FR2490963B1 (fr) * 1980-09-30 1986-04-18 Science Union & Cie Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine
KR850006132A (ko) * 1984-02-29 1985-10-02 진 크라메르, 한스 루돌프 하우스 브로모크립틴 조성물
JPS61293931A (ja) * 1985-06-24 1986-12-24 Teijin Ltd 徐放性医薬品組成物
JPH0625055B2 (ja) * 1985-03-18 1994-04-06 日本ケミフア株式会社 持続性錠剤
EP0207638B1 (de) † 1985-06-04 1990-12-19 Teijin Limited Arzneizubereitung mit verzögerter Wirkstoffabgabe
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
FR2681324B1 (fr) * 1991-09-18 1993-10-29 Adir Cie Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant.
KR940021051A (ko) * 1993-03-03 1994-10-17 손정삼 3단계 약물방출형 지속성 정제
RU2082400C1 (ru) * 1993-12-16 1997-06-27 Акционерное общество - Фармацевтическая фирма "Ник-Фарм" Способ получения нитроглицерина пролонгированного действия
FR2717687B1 (fr) * 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.

Also Published As

Publication number Publication date
BG65773B1 (bg) 2009-11-30
HUP0004966A3 (en) 2008-04-28
WO2001043747A8 (fr) 2001-09-07
CZ20022082A3 (cs) 2002-09-11
PL344564A1 (en) 2001-06-18
AU7228500A (en) 2001-06-21
ZA200007548B (en) 2001-06-19
JP2001172181A (ja) 2001-06-26
MXPA00012462A (es) 2002-06-04
SK286752B6 (sk) 2009-04-06
EA200001201A3 (ru) 2001-10-22
PT102542A (pt) 2001-06-29
HUP0004966A2 (en) 2002-06-29
DE60020501T3 (de) 2014-03-20
AU780011B2 (en) 2005-02-24
ES2176106A1 (es) 2002-11-16
PT1108424E (pt) 2005-08-31
IT1317075B1 (it) 2003-05-26
FR2802424B1 (fr) 2002-02-15
SI1108424T1 (en) 2005-10-31
ITRM20000667A0 (it) 2000-12-14
NZ508912A (en) 2002-04-26
SI1108424T2 (sl) 2014-02-28
EP1108424B1 (de) 2005-06-01
CY2347B1 (en) 2004-06-04
EA200001201A2 (ru) 2001-08-27
PL206994B1 (pl) 2010-10-29
HK1036937A1 (en) 2002-01-25
WO2001043747A1 (fr) 2001-06-21
EA200501901A1 (ru) 2006-06-30
JP2007314578A (ja) 2007-12-06
BR0005915A (pt) 2001-10-02
LU90700B1 (fr) 2007-12-03
DE60020501D1 (de) 2005-07-07
IE20001017A1 (en) 2002-04-03
DE60020501T2 (de) 2006-04-27
HU226956B1 (en) 2010-03-29
CN1302663A (zh) 2001-07-11
KR20010062478A (ko) 2001-07-07
ITRM20000667A1 (it) 2002-06-14
AR026968A1 (es) 2003-03-05
KR100456933B1 (ko) 2004-11-10
DK1108424T4 (da) 2013-12-16
GR1003658B (el) 2001-09-05
CZ299461B6 (cs) 2008-08-06
ATE296622T1 (de) 2005-06-15
EP1108424A1 (de) 2001-06-20
ES2240033T3 (es) 2005-10-16
CN1166408C (zh) 2004-09-15
EP1108424B2 (de) 2013-09-04
GEP20053540B (en) 2005-06-10
DK1108424T3 (da) 2005-10-03
ES2240033T5 (es) 2014-01-16
HU0004966D0 (de) 2001-02-28
ES2176106B1 (es) 2004-01-16
FR2802424A1 (fr) 2001-06-22
UA80087C2 (en) 2007-08-27
BG106927A (en) 2003-05-30
EA008223B1 (ru) 2007-04-27
SK8632002A3 (en) 2002-10-08

Similar Documents

Publication Publication Date Title
OA12121A (en) Matrix tablet for prolonged release of trimetazidine after oral administration.
EP1274402B1 (de) Arzneimittel zur gesteuerten freisetzung von paracetamol
PT88099B (pt) Processo para a preparacao de composicoes farmaceuticas de acetaminofeno orais e de libertacao prolongada
PT1945186E (pt) Composições farmacêuticas orais sólidas para dosagem uma vez ao dia contendo pregabalina, um agente de formação de matriz e um agente de intumescimento
MXPA01002599A (es) Formulaciones de ranolazina de liberacion sostenida.
KR20010086062A (ko) 고가용성 약물용 서방성 메트리스 시스템
AU2001260212A1 (en) Composition
EP0500851A1 (de) Verfahren zur herstellung einer einen wärme-, licht- und feuchtigkeit empfindlichen wirkstoff mit einer monoklinisch kristallinen struktur enthaltenden tabletten oder dragee zusammensetzung.
EP0284849A1 (de) Tabletten mit verzögerter Freisetzung auf der Basis von hochmolekularer Hydroxypropylmethylcellulose und Verfahren zu ihrer Herstellung
KR20050035250A (ko) 바이시파딘 포뮬레이션
PL191767B1 (pl) Stabilizowane przed racemizacją stałe lub ciekłe preparaty farmaceutyczne zawierające jako składnik czynny cilansetron, sposób wytwarzania stabilizowanych przed racemizacją stałych preparatów farmaceutycznych zawierających jako składnik czynny cilansetron oraz zastosowanie dopuszczalnych fizjologicznie rozpuszczalnych w wodzie kwaśnych dodatków
EP1104673A1 (de) Ein Hydrogencarbonat enthaltendes sprengmittelfreies Arzneimittel
WO2000013675A9 (en) Methazolamide compositions and method of use
KR20050085386A (ko) 불안증 치료 방법 및 조성물